標(biāo)題: Titlebook: Eicosanoids and the Gastrointestinal Tract; Keith Hillier (Senior Lecturer) Book 1988 MTP Press Limited 1988 gastrointestinal tract [打印本頁] 作者: ergonomics 時間: 2025-3-21 17:20
書目名稱Eicosanoids and the Gastrointestinal Tract影響因子(影響力)
書目名稱Eicosanoids and the Gastrointestinal Tract影響因子(影響力)學(xué)科排名
書目名稱Eicosanoids and the Gastrointestinal Tract網(wǎng)絡(luò)公開度
書目名稱Eicosanoids and the Gastrointestinal Tract網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Eicosanoids and the Gastrointestinal Tract被引頻次
書目名稱Eicosanoids and the Gastrointestinal Tract被引頻次學(xué)科排名
書目名稱Eicosanoids and the Gastrointestinal Tract年度引用
書目名稱Eicosanoids and the Gastrointestinal Tract年度引用學(xué)科排名
書目名稱Eicosanoids and the Gastrointestinal Tract讀者反饋
書目名稱Eicosanoids and the Gastrointestinal Tract讀者反饋學(xué)科排名
作者: 模仿 時間: 2025-3-21 23:52
Interplay between anti-inflammatory drugs and eicosanoids in gastrointestinal damage, in the fundamental actions of PGs and other eicosanoids on the GI tract and the actions of NSAIDs and steroids on their generation and actions. It is the purpose of this review to focus on (a) the actions of anti-inflammatory drugs on eicosanoid metabolism, and (b) the possible relationship of thes作者: 性冷淡 時間: 2025-3-22 03:05 作者: Chandelier 時間: 2025-3-22 07:13 作者: abstemious 時間: 2025-3-22 11:42 作者: 空中 時間: 2025-3-22 16:41 作者: 空中 時間: 2025-3-22 21:02
GUI for PSBN-based decision verificationhe major aggressive factor, i.e. gastric acid—pepsin secretion. The progress in this direction has been highlighted by the discoveries of powerful inhibitors of the parietal cell receptors such as H2-receptor antagonists (Cimetidine and ranitidine), muscarinic receptor (Ml and M2) inhibitors (pirenz作者: delegate 時間: 2025-3-22 21:25
Prevention and Management of OHSSby which prostaglandins, given at non-antisecretory doses, prevent gastric and intestinal mucosal necrosis produced by a variety of noxious agents. This property was first demonstrated in experimental animals and has been reproduced in humans. Gastric cytoprotection can be divided into three types: 作者: 窒息 時間: 2025-3-23 03:55 作者: 奇怪 時間: 2025-3-23 09:37 作者: 跟隨 時間: 2025-3-23 12:59 作者: gerrymander 時間: 2025-3-23 17:18 作者: Ligament 時間: 2025-3-23 21:23 作者: WAG 時間: 2025-3-24 01:58 作者: 冷淡一切 時間: 2025-3-24 04:07
Development of Antibody-Based TherapeuticsThe aetiology and the pathogenesis of inflammatory bowel disease (IBD) are still obscure. Infective agents and immunological mechanisms, as well as environmental and dietary factors. have been and are extensively investigated.作者: 最高峰 時間: 2025-3-24 10:25 作者: 泥瓦匠 時間: 2025-3-24 12:21
The role of eicosanoids in inflammatory bowel disease,The aetiology and the pathogenesis of inflammatory bowel disease (IBD) are still obscure. Infective agents and immunological mechanisms, as well as environmental and dietary factors. have been and are extensively investigated.作者: DEFT 時間: 2025-3-24 16:22 作者: 鋼盔 時間: 2025-3-24 20:38
Advances in Eicosanoid Researchhttp://image.papertrans.cn/e/image/303159.jpg作者: 自戀 時間: 2025-3-25 01:38
https://doi.org/10.1007/978-94-009-1281-6gastrointestinal tract作者: 組成 時間: 2025-3-25 06:56
978-94-010-7069-0MTP Press Limited 1988作者: 梯田 時間: 2025-3-25 10:07
nd 1976. A glance at those books illustrates the progress that has been made since then. The thromboxanes were mentioned twice (first publication 1975) and prostacyclin not once (first publication 1976); leukotrienes were only on the horizon. The amazing generation of research data in the last 10-15作者: Trabeculoplasty 時間: 2025-3-25 14:05
Prevention and Management of OHSSis property was first demonstrated in experimental animals and has been reproduced in humans. Gastric cytoprotection can be divided into three types: direct, adaptive and functional. We shall review the experimental evidence for each type of cytoprotection, present data on duodenal cytoprotection, and discuss hypotheses to explain the phenomenon.作者: 大罵 時間: 2025-3-25 18:35 作者: modest 時間: 2025-3-25 21:18 作者: 藐視 時間: 2025-3-26 02:49
Clinical uses of prostaglandins in peptic ulcer disease,epine) and possible gastrin-receptor inhibitors (proglumide). Furthermore, the inhibitors of second messengers of the parietal cells (calcium ions and cyclic AMP), such as calcium-channel blockers and prostaglandins as well as proton pump inhibitors (omeprazole), have been added to the spectrum of acid suppressing therapeutic agents.作者: 干旱 時間: 2025-3-26 05:32
Protection against mucosal damage: Mechanism of action of eicosanoids,is property was first demonstrated in experimental animals and has been reproduced in humans. Gastric cytoprotection can be divided into three types: direct, adaptive and functional. We shall review the experimental evidence for each type of cytoprotection, present data on duodenal cytoprotection, and discuss hypotheses to explain the phenomenon.作者: 濕潤 時間: 2025-3-26 09:36 作者: 橫截,橫斷 時間: 2025-3-26 15:21 作者: 語言學(xué) 時間: 2025-3-26 18:53
GUI for PSBN-based decision verificationepine) and possible gastrin-receptor inhibitors (proglumide). Furthermore, the inhibitors of second messengers of the parietal cells (calcium ions and cyclic AMP), such as calcium-channel blockers and prostaglandins as well as proton pump inhibitors (omeprazole), have been added to the spectrum of acid suppressing therapeutic agents.作者: 逢迎春日 時間: 2025-3-26 23:15 作者: GULLY 時間: 2025-3-27 03:42 作者: 聯(lián)合 時間: 2025-3-27 07:21 作者: 反抗者 時間: 2025-3-27 11:47
Alkaline secretion by the stomach and intestine: Effects of eicosanoids and anti-inflammatory drugstutes, along with the mucus layer, a first line of defence against acid in the stomach, and it is probably a principal protective mechanism in the duodenum.. In addition, bicarbonate secretion by the duodenal mucosa is considerably greater (per unit surface area) than in the stomach..作者: 他很靈活 時間: 2025-3-27 16:14 作者: opinionated 時間: 2025-3-27 19:45 作者: FADE 時間: 2025-3-28 01:05
Clinical uses of prostaglandins in peptic ulcer disease,he major aggressive factor, i.e. gastric acid—pepsin secretion. The progress in this direction has been highlighted by the discoveries of powerful inhibitors of the parietal cell receptors such as H2-receptor antagonists (Cimetidine and ranitidine), muscarinic receptor (Ml and M2) inhibitors (pirenz作者: RLS898 時間: 2025-3-28 03:22
Protection against mucosal damage: Mechanism of action of eicosanoids,by which prostaglandins, given at non-antisecretory doses, prevent gastric and intestinal mucosal necrosis produced by a variety of noxious agents. This property was first demonstrated in experimental animals and has been reproduced in humans. Gastric cytoprotection can be divided into three types: 作者: 幸福愉悅感 時間: 2025-3-28 07:23 作者: Magnificent 時間: 2025-3-28 12:52 作者: fodlder 時間: 2025-3-28 17:07 作者: tic-douloureux 時間: 2025-3-28 20:52
Effect of eicosanoids on gastrointestinal blood flow and microcirculation,ursors and potent biological actions.. The group encompasses the prostanoids., the thromboxanes., the leukotrienes., the 5-, 12- and 15-hydroxy and hydroperoxy fatty acids. and two newly described family of compounds: the lipoxins. and products derived from the metabolism of arachidonic acid by cyto作者: Intractable 時間: 2025-3-28 23:25 作者: 新手 時間: 2025-3-29 03:21
9樓作者: Tinea-Capitis 時間: 2025-3-29 09:52
9樓作者: AUGER 時間: 2025-3-29 12:50
10樓作者: 輕率看法 時間: 2025-3-29 17:01
10樓作者: 加劇 時間: 2025-3-29 20:11
10樓作者: 警告 時間: 2025-3-30 02:02
10樓
